Transient no reflow following primary percutaneous coronary intervention

被引:21
作者
Jinnouchi, Hiroyuki [1 ]
Sakakura, Kenichi [1 ]
Wada, Hiroshi [1 ]
Arao, Kenshiro [1 ]
Kubo, Norifumi [1 ]
Sugawara, Yoshitaka [1 ]
Funayama, Hiroshi [1 ]
Momomura, Shin-ichi [1 ]
Ako, Junya [1 ]
机构
[1] Jichi Med Univ, Div Cardiovasc Med, Saitama Med Ctr, Omiya, Saitama 3308503, Japan
关键词
Transient no reflow; Persistent no reflow; Myocardial infarction; Percutaneous coronary intervention; ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS THROMBOLYTIC THERAPY; COMBINATION THERAPY; ANGIOPLASTY; PREDICTORS; THROMBUS; MANAGEMENT; FLOW;
D O I
10.1007/s00380-013-0379-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
No reflow following primary percutaneous coronary intervention (PCI) is a serious complication in the treatment of acute myocardial infarction. No reflow in some patients is reversible (transient no reflow), whereas no reflow in others persists until the end of the procedure (persistent no reflow). The aim of this study was to identify clinical features of transient no reflow following primary PCI. Consecutive patients with no reflow (n = 123) were enrolled following primary PCI. Among them, 59 patients were in the transient group and 64 in the persistent group. We compared clinical features and hospital outcomes between the two groups. Multivariate logistic regression analysis was performed to identify the determinants of transient no reflow. The transient group had a lower rate of in-hospital cardiac death than the persistent group (0 vs. 6.4 %, relatively, P = 0.018). There was a trend for a shorter length of hospital stay in the transient group. Multivariate logistic regression analysis identified initial thrombolysis in myocardial infarction (TIMI) flow grade 3 (OR 6.239, 95 % CI 1.727-22.541, P = 0.005) and a higher estimated glomerular filtration rate (OR 1.204, 95 % CI 1.006-1.440, P = 0.042) as independent predictors of transient no reflow. Transient no reflow tended to be associated with TIMI thrombus grade a parts per thousand currency sign3 (OR 2.879, 95 % CI 0.928-8.931, P = 0.067). In conclusion, initial TIMI flow grade 3 and preserved renal function were associated with recovery from no reflow. Initial angiographic finding such as TIMI flow or TIMI thrombus grade might be an important predictor of recovery from the no-reflow phenomenon.
引用
收藏
页码:429 / 436
页数:8
相关论文
共 27 条
[1]   EARLY AND 1-YEAR CLINICAL OUTCOME OF PATIENTS EVOLVING NON-Q-WAVE VERSUS Q-WAVE MYOCARDIAL-INFARCTION AFTER THROMBOLYSIS - RESULTS FROM THE TIMI-II STUDY [J].
AGUIRRE, FV ;
YOUNIS, LT ;
CHAITMAN, BR ;
ROSS, AM ;
MCMAHON, RP ;
KERN, MJ ;
BERGER, PB ;
SOPKO, G ;
ROGERS, WJ ;
SHAW, L ;
KNATTERUD, G ;
BRAUNWALD, E .
CIRCULATION, 1995, 91 (10) :2541-2548
[2]   Angiographic evolution of intracoronary thrombus and dissection following percutaneous transluminal coronary angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial) [J].
Ambrose, JA ;
Almeida, OD ;
Sharma, SK ;
Dangas, G ;
Ratner, DE ;
Torre, SR ;
Marmur, JD ;
Israel, DH ;
Cohen, M ;
LaForgia, S ;
Weiss, MB ;
HjemdahlMonsen, CE ;
Treulieb, N ;
Myler, RK ;
Shaw, R ;
Ward, K ;
Moses, J ;
Wilentz, J ;
Manikian, A ;
Undemir, C ;
Cohen, N ;
Unterecker, WJ ;
Ogilby, D ;
Hart, B ;
Grunwald, AM ;
Koss, J ;
Sauer, D ;
Garret, JS ;
Lagrotteria, J ;
Cowley, MJ ;
DeBottis, D ;
Anwar, A ;
Petrard, G ;
Sobolski, J ;
Barker, WM ;
Teoh, N ;
Sweeney, JM ;
Schuerr, D ;
Frederick, L ;
Wallenstein, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (05) :559-563
[3]   Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon [J].
Barcin, C ;
Denktas, AE ;
Lennon, RJ ;
Hammes, L ;
Higano, ST ;
Holmes, DR ;
Garratt, KN ;
Lerman, A .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 61 (04) :484-491
[4]   Management of the no-reflow phenomenon [J].
Butler, Michelle J. ;
Chan, William ;
Taylor, Andrew J. ;
Dart, Anthony M. ;
Duffy, Stephen J. .
PHARMACOLOGY & THERAPEUTICS, 2011, 132 (01) :72-85
[5]   Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following Percutaneous Coronary Intervention [J].
Chan, William ;
Stub, Dion ;
Clark, David J. ;
Ajani, Andrew E. ;
Andrianopoulos, Nick ;
Brennan, Angela L. ;
New, Gishel ;
Black, Alexander ;
Shaw, James A. ;
Reid, Christopher M. ;
Dart, Anthony M. ;
Duffy, Stephen J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (04) :478-485
[6]   Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention [J].
Chen, Yundai ;
Wang, Changhua ;
Yang, Xinchun ;
Wang, Lefeng ;
Sun, Zhijun ;
Liu, Hongbin ;
Chen, Lian .
HEART AND VESSELS, 2012, 27 (03) :243-249
[7]   CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION [J].
ELLIS, SG ;
VANDORMAEL, MG ;
COWLEY, MJ ;
DISCIASCIO, G ;
DELIGONUL, U ;
TOPOL, EJ ;
BULLE, TM .
CIRCULATION, 1990, 82 (04) :1193-1202
[8]  
Gibson CM, 2001, CIRCULATION, V103, P2550
[9]   Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction [J].
Iwakura, K ;
Ito, H ;
Ikushima, M ;
Kawano, S ;
Okamura, A ;
Asano, K ;
Kuroda, T ;
Tanaka, K ;
Masuyama, T ;
Hori, M ;
Fujii, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :1-7
[10]   Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction [J].
Iwakura, K ;
Ito, H ;
Kawano, S ;
Shintani, Y ;
Yamamoto, K ;
Kato, A ;
Ikushima, M ;
Tanaka, K ;
Kitakaze, M ;
Hori, M ;
Higashino, Y ;
Fujii, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :472-477